Fostering Ethical Neurotechnology Academia-Industry Partnerships: A Stakeholder Engagement and Toolkit Development Project

促进道德神经技术学术界与工业界的伙伴关系：利益相关者参与和工具包开发项目

• 批准号: 10655632
• 负责人: Tristan McIntosh
• 金额: $ 34.99万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-07-01 至 2026-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10655632
• 关键词: Academia; Address; Adopted; Adoption; Area; BRAIN initiative; Behavior; Brain; Brain Diseases; Case Study; Clinical; Collaborations; Conflict of Interest; Consensus; Data; Development; Devices; Education; Effectiveness; Entrepreneurship; Ethical Issues; Ethicists; Ethics; Evaluation; Fostering; Funding; Goals; Health; Implant; Individual; Industry; Interview; Marketing; Mediation; Mission; Monitor; Online Systems; Patients; Perception; Play; Policies; Privatization; Process; Recommendation; Reporting; Research; Research Contracts; Research Personnel; Resources; Risk Factors; Role; Series; Shapes; Surveys; Technology Transfer; Translation Process; Universities; clinical practice; cognitive interview; commercialization; data sharing; design; financial incentive; health data; industry partner; innovation; innovative neurotechnologies; member; neurotechnology; open data; outreach; prevent; recruit; risk mitigation; stakeholder perspectives; transmission process; webinar

Project Summary Neurotechnologies used to treat brain disorders and diseases can drastically change brain function and behavior, monitor brain activity, and collect and transmit personal health data. Industry-academia (IA) partnerships play a critical role in bringing neurotechnologies to market for public benefit. However, there are significant ethical issues that emerge from these partnerships, especially given the unique capacities of neurotechnologies. If these ethical challenges are not handled appropriately, scientific integrity can be undermined and the objectivity in the design, development, and commercialization of neurotechnologies can be jeopardized. This project addresses a gap in our current understanding of ethical complexities in industry-academia (IA) partnerships within the neurotechnology enterprise by engaging relevant neurotechnology stakeholders (e.g., industry, researchers, ethicists, university officials, patients) to identify promising and practical solutions for addressing these ethical complexities. This project builds logically across three aims that culminate in the development, dissemination, and evaluation of a toolkit that includes stakeholder-informed guidance for ethically and responsibly navigating IA neurotechnology partnerships. Aim 1 will use in-depth interviews with neurotechnology stakeholders to identify risk factors and ethical challenges for IA partnerships, including in the design, conduct, reporting, and application of neurotechnology research. Aim 2 will involve a Delphi consensus panel of neurotechnology stakeholders to establish best practices and solutions for mitigating risk and addressing ethical issues that emerge from IA partnerships. Aim 3 will include developing, disseminating, and evaluating a toolkit that provides guidance and resources for neurotechnology stakeholders to help them ethically and responsibly navigate neurotechnology IA partnerships. We will recommend adoption of specific solutions for each stakeholder group. This is the first project to systematically and simultaneously engage diverse neurotechnology stakeholders to develop practical and actionable guidance for ethical and responsible IA neurotechnology partnerships. We will develop the first publicly accessible stakeholder-informed toolkit that can be adapted to current and forthcoming neurotechnologies resulting from IA partnerships. Taken together, this project will have considerable impact on the conduct of neurotechnology research by identifying practical solutions for balancing scientific values with fiduciary goals.

项目摘要 用于治疗脑部疾病和疾病的神经技术可以大大改变脑功能和行为， 监控大脑活动，并收集和传输个人健康数据。行业 - 阿卡迪亚（IA）合作伙伴关系 为了公共利益，将神经技术推向市场上的关键作用。但是，有重大的道德 从这些伙伴关系中产生的问题，特别是考虑到神经技术的独特能力。如果这些 道德挑战没有适当处理，科学完整性可能会受到破坏，并且客观性 神经技术的设计，开发和商业化可能会受到危害。 该项目解决了我们当前对行业 - 核心（IA）道德复杂性的理解的差距（IA） 通过参与相关神经技术利益相关者（例如， 行业，研究人员，伦理学家，大学官员，患者），以确定有前途和实用的解决方案 解决这些道德复杂性。该项目以逻辑为逻辑，跨三个目标 工具包的开发，传播和评估，其中包括利益相关者的道德指南 并负责任地导航IA神经技术伙伴关系。 AIM 1将使用与神经技术利益相关者的深入访谈来确定风险因素和道德因素 IA合作伙伴关系的挑战，包括在设计，行为，报告和应用神经技术的挑战 研究。 AIM 2将涉及神经技术利益相关者的Delphi共识小组以建立最佳 降低风险并解决IA合作伙伴关系的道德问题的实践和解决方案。目的 3将包括开发，传播和评估工具包，以提供指导和资源 神经技术利益相关者在道德和负责任地导航神经技术IA伙伴关系。 我们将建议为每个利益相关者群体采用特定解决方案。 这是第一个系统地和同时吸引各种神经技术利益相关者的项目 为道德和负责任的IA神经技术伙伴关系制定实用和可行的指导。我们将 开发第一个可公开访问的利益相关者信息包，可以适应当前和即将到来的 IA伙伴关系产生的神经技术。综上所述，该项目将对 通过确定将科学价值与科学价值平衡的实用解决方案与 信托目标。